ArticleExperimental physiology2026
S14G-humanin attenuates renal ischaemia-reperfusion injury, potentially through activation of STAT3 and ERK1/2 signalling pathways in rats.
Article in Experimental physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- S14G-humanin attenuates renal ischaemia-reperfusion injury, potentially through activation of STAT3 and ERK1/2 signalling pathways in rats.Experimental physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Renal ischaemia-reperfusion (I/R) injury leads to acute tubular necrosis and renal failure, triggering pathological mechanisms including inflammation, reactive oxygen species generation, apoptosis and mitochondrial dysfunction. The mitochondrial peptide humanin (HN), known to possess anti-apoptotic and anti-inflammatory properties, has been shown to counteract oxidative stress and restore mitochondrial function. This study aimed to investigate the effects of S14G-humanin (humanin G, HNG) on renal I/R injury. Sprague-Dawley male rats were divided into four groups (n = 48): (1) Sham, (2) I/R, (3) HNG-Sham, and (4) HNG-I/R. In I/R groups, renal artery ligation was performed for 45 min followed by 24-h reperfusion. HNG (2 mg/kg, i.v.) was administered 10 min before reperfusion. Urine was collected during reperfusion, and the experiment was terminated by collecting blood and tissue samples. Blood urea nitrogen and serum creatinine levels were elevated in the I/R group and were not affected by HNG treatment. Glutathione level and superoxide dismutase activity, which were diminished in the I/R group, were significantly restored following HNG administration. Myeloperoxidase activity and malondialdehyde levels were significantly decreased in HNG-I/R group compared to the I/R group. ATP levels and mitochondrial complex I activity were significantly increased in the HNG-I/R group compared to I/R. The percentage of apoptotic cells, markedly increased in I/R, was significantly reduced in HNG-I/R. Signal transducer and activator of transcription 3 (STAT3) and extracellular signal-regulated kinases 1 and 2 (ERK1/2) phosphorylation also increased in HNG-I/R rats compared to I/R animals. HNG mitigates renal I/R injury by attenuating oxidative stress, inflammation and apoptosis while enhancing antioxidant capacity and mitochondrial function, through STAT3 and/or ERK1/2 activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.